Related Experiment Video
Updated: Jul 7, 2026

Assessing Bacterial Invasion of Cardiac Cells in Culture and Heart Colonization in Infected Mice Using Listeria monocytogenes
Published on: May 27, 2015
Infective endocarditis due to Lactococcus garvieae, an unusual emerging pathogen
Kumudhavalli Kavanoor Sridhar1, Matthew Paul Muller2
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario.
Background:
Lactococcus garvieae is an emerging, fish-associated zoonotic pathogen that rarely causes human infection but is increasingly linked to serious conditions like infective endocarditis (IE). Lactococcus spp are phylogenetically and phenotypically related to Streptococcus and Enterococcus spp as all three genera are gram-positive, catalase-negative, lactic acid-producing cocci that belong to the family Streptococcaceae. Due to these shared characteristics, L. garvieae is frequently misidentified by traditional biochemical methods, necessitating advanced techniques for definitive diagnosis.
Case Presentation:
We present the case of a 61-year-old male patient with native valve IE secondary to L. garvieae. This represents only the second reported Canadian case of L. garvieae IE and is unique in that the infection involved the native aortic valve despite the presence of a mechanical valve. Furthermore, the case is characterized by an occult source of inoculation as the patient lacked the typical risk factors of raw seafood consumption or occupational exposure to aquaculture. This clinical presentation underscores the importance of considering L. garvieae in the differential diagnosis of IE, even in the absence of traditional zoonotic links.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Bacterial Meningitis II: Pathophysiology
